Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Sep 10, 2013 at 12:20 PM EDT

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change…

Paul Ausick | Aug 16, 2013 at 4:06 PM EDT

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

August 16, 2013: U.S. equity markets opened lower this morning following big down day on Thursday. In the U.S., the…

Paul Ausick | Aug 6, 2013 at 2:03 PM EDT

Can Facebook Become the Market’s Volume Leader?

Brian Solis, via Wikimedia CommonsOn the day that Facebook Inc. (NASDAQ: FB) came public last year, more than 580 million…

Paul Ausick | Jul 30, 2013 at 4:07 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

July 30, 2013: U.S. equity markets opened higher this morning as traders and investors wait for tomorrow’s announcement from the…

Jon C. Ogg | Jul 29, 2013 at 3:28 PM EDT

Pfizer Restructuring May Precede Total Breakup of the Empire

Wikimedia CommonsWhenever you see huge restructurings and reclassifications for a major corporation, the first thing that should come to mind…

Jon C. Ogg | Jul 25, 2013 at 9:35 AM EDT

Short Sellers Make Big Changes in High-Yield Dividend Stocks

ThinkstockShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in…

Paul Ausick | Jul 19, 2013 at 2:50 PM EDT

Stephen Cohen Charged with Failing Supervision in Insider Trading Case

ThinkstockStephen A. Cohen, the founder and owner of SAC Capital Advisors LLC, has been charged by the U.S. Securities and…

Paul Ausick | Jul 12, 2013 at 4:07 PM EDT

Closing Bell for Friday on Wall Street: Markets Stagger to Modest Gains

July 12, 2013: U.S. equity markets opened slightly higher this morning as European industrial production was below expectations and U.S.…

Jon C. Ogg | Jul 12, 2013 at 8:25 AM EDT

Top 10 Analyst Upgrades and Downgrades: F5 Networks, Pfizer, Sprint and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Friday, July 12, 2013.…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Douglas A. McIntyre | Jun 28, 2013 at 3:41 AM EDT

Pfizer Ups Stock Buyback to $10 Billion

Wikimedia CommonsIn a sign that Pfizer Inc. (NYSE: PFE) has more cash on hand than the sense to use it…

Jon C. Ogg | Jun 26, 2013 at 11:25 AM EDT

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Jon OggShort sellers have really made some big changes in their bets against the key high-yield dividend stocks that had…

Jon C. Ogg | Jun 24, 2013 at 8:30 AM EDT

Oppenheimer Resumes Coverage of Biotechnology With Top Stocks to Buy

ThinkstockEven the best firms on Wall Street sometimes lose their analysts, and when that happens they are forced to suspend…

Jon C. Ogg | Jun 6, 2013 at 8:00 AM EDT

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum…

Jon C. Ogg | May 31, 2013 at 2:22 PM EDT

Rising Interest Rate Risk For Big Dividends, Sector By Sector

Jon OggThe bull market appears to still be alive and well for equities, but the risk of rising interest rates…

1 … 68 69 70 71 72 … 98

Pfizer : PFE

All Pfizer Articles

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Can Facebook Become the Market’s Volume Leader?

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

Pfizer Restructuring May Precede Total Breakup of the Empire

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Stephen Cohen Charged with Failing Supervision in Insider Trading Case

Closing Bell for Friday on Wall Street: Markets Stagger to Modest Gains

Top 10 Analyst Upgrades and Downgrades: F5 Networks, Pfizer, Sprint and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Pfizer Ups Stock Buyback to $10 Billion

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Oppenheimer Resumes Coverage of Biotechnology With Top Stocks to Buy

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Rising Interest Rate Risk For Big Dividends, Sector By Sector

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Pfizer : PFE

All Pfizer Articles

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Can Facebook Become the Market’s Volume Leader?

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

Pfizer Restructuring May Precede Total Breakup of the Empire

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Stephen Cohen Charged with Failing Supervision in Insider Trading Case

Closing Bell for Friday on Wall Street: Markets Stagger to Modest Gains

Top 10 Analyst Upgrades and Downgrades: F5 Networks, Pfizer, Sprint and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Pfizer Ups Stock Buyback to $10 Billion

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Oppenheimer Resumes Coverage of Biotechnology With Top Stocks to Buy

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Rising Interest Rate Risk For Big Dividends, Sector By Sector

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts